MedPath

Importance of Sleep Deprivation in Differential Diagnosis of Primary Hypersomnia (Actisom dépistage)

Completed
Conditions
Hypersomnia
Registration Number
NCT03459300
Lead Sponsor
Centre d'Investigation Clinique et Technologique 805
Brief Summary

7 to 14 days actimetry recording in order to exclude sleep deprivation just before hospitalisation for differential diagnosis of hypersomnia

Detailed Description

This is an observational study

Urine drug screening will also be performe

The suty includes four centers in France

The study duration is of one year

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Men or women aged > 18 years
  • Patient with a sleepiness evoking a primary hypersomnia
  • Epworth sleepiness scale > 10
  • Information note signed
Exclusion Criteria
  • Patient with type 1 or 2 narcolepsy and/or known hypersomnia
  • Frank cataplexy
  • Not stable metabolic, neurological or psychiatric disease
  • Patient treated by a medicine acting on the central nervous system
  • Patient having a shift work or having made a transmeridian flight of more than 3 hours lag in the previous month the research
  • Non affiliation to social security
  • Pregnancy
  • Patient under guardianship or curatorship

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
mean total sleep time7-14 days before hospitalisation

mean total sleep time as measured by actimetry durind the 7 - 14 days before hospitalisation

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Hôpital raymond Poincaré

🇫🇷

Garches, Ile De France, France

© Copyright 2025. All Rights Reserved by MedPath